Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 7, 2013, Pages 449-457

  Guo, Qiu Hong ^a   Tian, Yi Long ^a   Wang, Zhuo ^a   Li, Ai Ying ^a   Ma, Zhi Hong ^a   Guo, Ya Jing ^a   Weiss, J Woodrow ^b   Ji, En Sheng ^a   Chu, Li ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aorta; Chronic intermittent hypoxia; Endothelin receptors; Endothelin 1

Indexed keywords

ACETYLCHOLINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CHRONIC INTERMITTENT HYPOXIA; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; GENE OVEREXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PATHOGENESIS; RAT; WESTERN BLOTTING;

ANIMALS; ANOXIA; AORTA; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; VASOCONSTRICTION; VASODILATION;

EID: 84879544752     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12109     Document Type: Article

References (37)

1. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000; 342: 1378-84.
2. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med. 1997; 157: 1746-52.
3. Dart RA, Gregoire JR, Gutterman DD, Woolf SH. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003; 123: 244-60.
4. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001; 163: 19-25.
5. Saarelainen S, Seppala E, Laasonen K, Hasan J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5: 115-18.
6. Trakada G, Marangos M, Spiropoulos K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin desaturation. Respiration 2001; 68: 134-9.
7. Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF. Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis. Pharmacol. Ther. 2006; 111: 508-31.
8. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001; 37: 511-15.
9. Davenport AP. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol. Rev. 2002; 54: 219-26.
10. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 1994; 46: 137-42.
11. Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 1999; 61: 391-415.
12. Maguire JJ, Davenport AP. Endothelin receptor expression and pharmacology in human saphenous vein graft. Br. J. Pharmacol. 1999; 126: 443-50.
13. Shetty SS, Okada T, De Webb RLI, Grande D, Lappe RW. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 1993; 191: 459-64.
14. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res. 2007; 76: 8-18.
15. Allahdadi KJ, Cherng TW, Pai H et al. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H434-40.
16. B receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men. Clin. Sci. 2003; 104: 143-51.
17. Lefebvre B, Godin-Ribuot D, Joyeux-Faure M et al. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir. Physiol. Neurobiol. 2006; 150: 278-86.
18. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H388-93.
19. Thomas BJ, Wanstall JC. Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. Eur. J. Pharmacol. 2003; 477: 153-61.
20. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J. Appl. Physiol. 2001; 90: 2007-13.
21. Liu Y, Ji ES, Xiang S et al. Exposure to cyclic intermittent hypoxia increases expression of functional NMDA receptors in the rat carotid body. J. Appl. Physiol. 2009; 106: 259-67.
22. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J. Clin. Invest. 1997; 99: 106-9.
23. Parker JD, Brooks D, Kozar LF et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am. J. Respir. Crit. Care Med. 1999; 160: 1888-96.
24. Fletcher EC. Physiological consequences of intermittent hypoxia: Systemic blood pressure. J. Appl. Physiol. 2001; 90: 1600-5.
25. B-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol. 1994; 23: 838-45.
26. Higashi T, Ishizaki T, Shigemori K et al. Pharmacological heterogeneity of constrictions mediated by endothelin receptors in rat pulmonary arteries. Am. J. Physiol. 1997; 272: L287-93.
27. Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am. J. Respir. Cell Mol. Biol. 1999; 20: 620-30.
28. Zhou Y, Dirksen WP, Zweier JL, Periasamy M. Endothelin-1-induced responses in isolated mouse vessels: The expression and function of receptor types. Am. J. Physiol. Heart Circ. Physiol. 2004; 287: H573-8.
29. Mizuguchi T, Nishiyama M, Moroi K et al. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br. J. Pharmacol. 1997; 120: 1427-30.
30. A receptors. Am. J. Physiol. Renal Physiol. 2004; 286: F660-8.
31. Sylvester FA, Stepp DW, Frisbee JC, Lombard JH. High-salt diet depresses acetylcholine reactivity proximal to NOS activation in cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H353-63.
32. Philippi NR, Bird CE, Marcus NJ, Olson EB, Chesler NC, Morgan BJ. Time course of intermittent hypoxia-induced impairments in resistance artery structure and function. Respir. Physiol. Neurobiol. 2010; 170: 157-63.
33. Parris RJ, Webb DJ. The endothelin system in cardiovascular physiology and pathophysiology. Vasc. Med. 1997; 2: 31-43.
34. Stuehr DJ. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 1999; 1411: 217-30.
35. Ushio-Fukai M, Nishimura J, Aoki H, Kobayashi S, Kanaide H. Endothelin-1 inhibits and enhances contraction of porcine coronary arterial strips with an intact endothelium. Biochem. Biophys. Res. Commun. 1992; 184: 518-24.
36. B receptors in arteries and veins: Multiple actions in the vein. J. Pharmacol. Exp. Ther. 2009; 329: 875-81.
37. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45: 705-9.